Synonyms: SUVN-D4010 | SUVND4010
Compound class:
Synthetic organic
Comment: Usmarapride (SUVN-D4010) is a 5-HT4 receptor partial agonist [1]. It was developed for potential to alleviate cognitive impairment associated with Alzheimer's disease.
|
|
No information available. |
Summary of Clinical Use |
SUVN-D4010 has progressed to clinical trial. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT02575482 | A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects | Phase 1 Interventional | Suven Life Sciences Limited | ||
NCT03031574 | A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-D4010 in Healthy Subjects | Phase 1 Interventional | Suven Life Sciences Limited |